Code: F7AMSHZT Health Technology Assessment
Lecturer: doc. Vladimír Rogalewicz CSc. Weekly load: 2P+2S Completion: A, EX
Department: 17110 Credits: 4 Semester: S
Contents:
- Introduction to HTA, the role of HTA, historical overview. HTA definition: specification of HTA, basic lines of HTA, the perspective of HTA studies. Scope of HTA. Utilization of HTA in decisions about reimbursement of a new technology. Utilization of HTA for strategic decisions in hospitals. Separation of assessment and decision-making.
- Evidence based medicine. Quality of information sources for EBM. Literature reviews: technique of literature reviews, databases of publications and research results, Cochrane Institute. Meta-analysis and its techniques. Data sources: international databases, Institute of Health Information and Statistics of the Czech Republic, retrospective data from healthcare providers and payers.
- Outcomes in the field of HTA: how to collect, process, calculate with them. Types used in HTA.
- Multiple-criteria methods for figuring out the outcomes. Measurement of quality of life: QALY, DALY, LYG, various ways how to measure QoL, generic and specific questionnaires, time trade-off, standard gamble.
- Costs and resources of cost data: direct medical costs, direct non-medical costs. Costs and resources of cost data: Indirect costs, intangible costs.
- Cost analyses: CMA, CEA, CUA, ICER, CBA, CIA, CCA. Economic-theoretical foundations of cost analyses. Modelling in HTA. Sensitivity analysis.
- Core model. NICE model. HTA for pharmaceuticals.
- Utilization of HTA in decision-making about reimbursement of a new technology. Inclusion of a new technology in the reimbursement system. Disinvestment. Budget-impact analysis (BIA). Willingness to pay. Threshold values and their introduction. Individual thresholds.
- HTA for medical devices. Suitable analyses, the assessment process. HB-HTA: Utilization of HTA at a single-hospital level.
- Organization and collaboration in HTA: Institutions at a national level, transfer of results between different healthcare systems. International societies and organizations. Ethics and HTA.
Seminar contents:
? Introduction to HTA, the role of HTA, historical overview. HTA definition: specification of HTA, basic lines of HTA, the perspective of HTA studies. Scope of HTA. Utilization of HTA in decisions about reimbursement of a new technology. Utilization of HTA for strategic decisions in hospitals. Separation of assessment and decision-making.
? Evidence based medicine. Quality of information sources for EBM. Literature reviews: technique of literature reviews, databases of publications and research results, Cochrane Institute. Meta-analysis and its techniques. Data sources: international databases, Institute of Health Information and Statistics of the Czech Republic, retrospective data from healthcare providers and payers.
? Outcomes in the field of HTA: how to collect, process, calculate with them. Types used in HTA.
? Multiple-criteria methods for figuring out the outcomes. Measurement of quality of life: QALY, DALY, LYG, various ways how to measure QoL, generic and specific questionnaires, time trade-off, standard gamble.
? Costs and resources of cost data: direct medical costs, direct non-medical costs. Costs and resources of cost data: Indirect costs, intangible costs.
? Cost analyses: CMA, CEA, CUA, ICER, CBA, CIA, CCA. Economic-theoretical foundations of cost analyses. Modelling in HTA. Sensitivity analysis.
? Core model. NICE model. HTA for pharmaceuticals.
? Utilization of HTA in decision-making about reimbursement of a new technology. Inclusion of a new technology in the reimbursement system. Disinvestment. Budget-impact analysis (BIA). Willingness to pay. Threshold values and their introduction. Individual thresholds.
? HTA for medical devices. Suitable analyses, the assessment process. HB-HTA: Utilization of HTA at a single-hospital level.
? Organization and collaboration in HTA: Institutions at a national level, transfer of results between different healthcare systems. International societies and organizations. Ethics and HTA.
Recommended literature:
Required:
[1]. GOODMAN, Clifford S.: HTA101. Introduction to Health Technology Assessment. The Lewin Group, Virginia, 2014. (Volnì dostupné z http://www.nlm.nih.gov/nichsr/hta101/HTA_101_FINAL_7-23-14.pdf)
[2]. BRENT, Robert J. Cost-benefit analysis and health care evaluations. Northhampton, MA: Edward Elgar, 2003. ISBN 978-1840648447.
[3]. SCHÖFFSKI, Oliver. a Johann-Matthias SCHULENBURG. Gesundheitsökonomische Evaluationen. 4., vollständig überarb. Aufl. Berlin: Springer, 2012. ISBN 978-3-642-21699-2.
Recommended:
www.czechhta.cz

Abbreviations used:

Semester:

Mode of completion of the course:

Weekly load (hours per week):